Experimental Hematology
Volume 38, Issue 8 , Pages 609-617, August 2010

Both Nramp1 and DMT1 are necessary for efficient macrophage iron recycling

  • Shan Soe-Lin

      Affiliations

    • Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada
    • Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada
  • ,
  • Sameer S. Apte

      Affiliations

    • Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada
  • ,
  • Marc R. Mikhael

      Affiliations

    • Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada
    • Department of Physiology, McGill University, Montreal, Quebec, Canada
  • ,
  • Lidia K. Kayembe

      Affiliations

    • Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada
  • ,
  • Guangjun Nie

      Affiliations

    • Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology of China, Beijing, China
  • ,
  • Prem Ponka

      Affiliations

    • Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada
    • Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada
    • Department of Physiology, McGill University, Montreal, Quebec, Canada
    • Corresponding Author InformationOffprint requests to: Prem Ponka, M.D., Ph.D., Lady Davis Institute for Medical Research, 3755 Cote St. Catharine, Montreal, Quebec H3T 1E2, Canada

Received 14 January 2010; received in revised form 5 April 2010; accepted 6 April 2010. published online 14 April 2010.

Objective

Divalent metal transporter 1 (DMT1) and natural resistance-associated macrophage protein 1 (Nramp1) are iron transporters that localize, respectively, to the early and late endosomal compartments. DMT1 is ubiquitously expressed, while Nramp1 is found only within macrophages and neutrophils. Our previous studies have identified a role for Nramp1 during macrophage erythrophagocytosis; however, little is known about the function of DMT1 during this process.

Materials and Methods

Wild-type RAW264.7 macrophages (RAW), and those stably transfected with Nramp1 (RAW/Nramp1) were treated with either DMT1−small interfering RNA, or with ebselen, a selective inhibitor of DMT1.

Results

Although macrophages lacking either functional DMT1 or Nramp1 experienced a moderate reduction in iron recycling efficiency, the ability of macrophages lacking both functional DMT1 and Nramp1 to recycle hemoglobin-derived iron was severely compromised. Compared to macrophages singly deficient in either DMT1 or Nramp1 transport ability, macrophages where DMT1 and Nramp1 were both compromised exhibited an abrogated increase in labile iron pool content, released less iron, and experienced diminished upregulation of ferroportin and heme-oxygenase 1 levels following erythrophagocytosis.

Conclusions

These results suggest that although the loss of either Nramp1 or DMT1 transport ability results in minor impairment after erythrophagocytosis, the simultaneous loss of both Nramp1 and DMT1 iron transport activity is detrimental to the iron recycling capacity of the macrophage.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0301-472X(10)00145-1

doi:10.1016/j.exphem.2010.04.003

Experimental Hematology
Volume 38, Issue 8 , Pages 609-617, August 2010